Medibank Private (MPL) Status Update summary

Strategic aspirations and growth targets

• Set FY 2030 aspiration to increase health segment earnings to at least AUD 200 million, growing from $76.7m in FY25, with disciplined capital allocation and a focus on both organic and inorganic growth.

• Targets an increase in resident PHI market share from 26.5% to over 26.8% by FY30, maintaining disciplined market share in PHI and supporting 10 million people in health and well-being by FY 2030.

• Growth strategy focuses on expanding health services, leveraging both organic and inorganic (M&A) opportunities, and scaling digital and preventative care.

• FY 2028 milestones include expanding Live Better to 1.2 million customers, growing corporate health, and increasing financial well-being policyholders to over 440,000.

• Capital deployment for M&A remains disciplined, with a base budget for Myhealth and additional investments considered for strategic opportunities.

Market context and system transformation

• Australian health system is world-class but faces rising demand, aging population, chronic disease, mental health needs, and workforce challenges.

• Four key shifts identified: treatment to prevention, hospital to community/home, analog to digital, and generic to personalized care.

• International case studies (South Africa, Singapore, Sweden, UK) highlight the value of multidisciplinary care, digital transformation, and precision medicine.

• Technology and data integration, including AI and remote monitoring, are central to enabling these shifts, improving outcomes, and reducing costs.

Technology and innovation as growth drivers

• Emphasizes the role of AI, remote monitoring, and digital health platforms in enabling scalable, connected care.

• Focuses on digital identity, interoperable health data, and virtual care to improve access, efficiency, and patient experience.

• Invests in genomics and data-driven precision care to support personalised medicine and proactive risk prevention.